4.3 Review

Voriconazole therapeutic drug monitoring: focus on safety

期刊

EXPERT OPINION ON DRUG SAFETY
卷 9, 期 1, 页码 125-137

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1517/14740330903485637

关键词

adverse effects; CYP2C19 protein; drug monitoring; drug toxicity; voriconazole

资金

  1. CAPES
  2. CNPq
  3. FAPERGS
  4. Myconostica
  5. Pfizer
  6. Merck
  7. Sigma-Tau

向作者/读者索取更多资源

Importance of the field: Voriconazole has been widely used for the treatment of invasive fungal diseases, particularly invasive aspergillosis. Drug drug interactions are, however, the main drawback associated with voriconazole use, since this drug suffers from extensive hepatic metabolism. Areas covered in this review: This article reviews the current literature on voriconazole therapeutic drug monitoring, with a special focus on drug safety. What the reader will gain: An update on voriconazole metabolism, drug interactions, toxicity and the relation of these with voriconazole drug concentrations. Take home message: Therapy with voriconazole may be better guided by measuring voriconazole concentrations in the plasma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据